Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114, USA.
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3825-31. doi: 10.1167/iovs.10-6797.
To investigate whether edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a free radical scavenger, would be neuroprotective against photoreceptor cell death in a rat model of retinal detachment (RD).
RD was induced in adult Brown Norway rats by subretinal injection of sodium hyaluronate. Edaravone (3, 5, or 10 mg/kg) or physiologic saline was administered intraperitoneally once a day until death on day 3 or 5. Oxidative stress in the retina was assessed by 4-hydroxynonenal staining or ELISA for protein carbonyl content. Photoreceptor death was assessed by TUNEL and measurement of the outer nuclear layer thickness. Western blot analysis and caspase activity assays were performed. Inflammatory cytokine secretion and inflammatory cell infiltration were evaluated by ELISA and immunostaining, respectively.
RD resulted in increased generation of ROS. Treatment with 5 mg/kg edaravone significantly reduced the ROS level, along with a decrease in TUNEL-positive cells in the photoreceptor layer. A caspase assay also confirmed decreased activation of caspase-3, -8, and -9 in RD treated with edaravone. The level of the antiapoptotic Bcl-2 was increased in detached retinas after edaravone treatment, whereas the levels of the stress-activated p-ERK1/2 were decreased. In addition, edaravone treatment resulted in a significant decrease in the levels of TNF-α, MCP-1, and macrophage infiltration.
Oxidative stress plays an important role in photoreceptor cell death after RD. Edaravone treatment may aid in preventing photoreceptor cell death after RD by suppressing ROS-induced photoreceptor damage.
研究自由基清除剂依达拉奉(3-甲基-1-苯基-2-吡唑啉-5-酮)是否对视网膜脱离(RD)大鼠模型中的光感受器细胞死亡具有神经保护作用。
通过视网膜下注射透明质酸钠在成年布朗-挪威大鼠中诱导 RD。依达拉奉(3、5 或 10 mg/kg)或生理盐水通过腹腔内注射每天一次,直至第 3 或第 5 天死亡。通过 4-羟壬烯醛染色或蛋白质羰基含量 ELISA 评估视网膜中的氧化应激。通过 TUNEL 和外核层厚度测量评估光感受器死亡。进行 Western blot 分析和半胱天冬酶活性测定。通过 ELISA 和免疫染色分别评估炎症细胞因子分泌和炎症细胞浸润。
RD 导致 ROS 的产生增加。用 5mg/kg 依达拉奉治疗可显著降低 ROS 水平,同时减少光感受器层中的 TUNEL 阳性细胞。半胱天冬酶测定也证实,依达拉奉处理的 RD 中 caspase-3、-8 和 -9 的激活减少。依达拉奉处理后,分离视网膜中抗凋亡 Bcl-2 的水平增加,而应激激活的 p-ERK1/2 水平降低。此外,依达拉奉治疗导致 TNF-α、MCP-1 和巨噬细胞浸润水平显著降低。
氧化应激在 RD 后光感受器细胞死亡中起重要作用。依达拉奉治疗可能通过抑制 ROS 诱导的光感受器损伤来帮助预防 RD 后的光感受器细胞死亡。